Championing Change: The WiMT Committee’s Mission to Advance Women in MedTech
The Women in MedTech (WiMT) Committee plays a pivotal role in driving gender equity and empowering women across Australia's MedTech industry. At its core, the committee is tasked with achieving the strategic mission set by the MTAA Board, ensuring tangible progress toward a more inclusive and representative sector.
A critical function of the committee is to track and analyse benchmark metrics on the current ratio of women in leadership positions, providing data-driven insights that highlight gaps and opportunities for improvement. Beyond measurement, the WiMT Committee leads industry-wide discussions to establish realistic and achievable targets for female leadership representation, fostering accountability and collective action.
To translate these goals into practice, the committee develops and shares actionable plans that companies can implement to expand their female talent pipelines and elevate women into leadership roles. These resources are complemented by high-profile campaigns and events, including annual awards, which amplify the visibility and contributions of women in MedTech—inspiring the next generation of leaders.
Additionally, the WiMT Committee creates practical tools and frameworks to help organisations address systemic barriers and embed diversity best practices into their operations. By combining data, advocacy, and actionable strategies, the committee serves as a catalyst for meaningful change, ensuring the MedTech industry not only recognises the value of women but actively empowers them to thrive at all levels.
This work is essential for building a stronger, more innovative, and equitable MedTech sector in Australia—one where diversity of thought and leadership drives sustained growth and success.
2025 Women in MedTech Committee Members
Member Name | Position | Company |
---|---|---|
Jane Crowe (Chair and Board Representative) | Managing Director, ANZ | Cardinal Health Australia Pty Ltd |
Warren Bingham (Board Representative) | Executive Chairman | MedTech International Pty Ltd |
Beth Roberts (Board Representative) | Managing Director | KLS Martin Australia Pty Ltd |
Sue Hansford | Managing Director | Integra Lifesciences Pty Ltd |
Bronwyn Calvert | Head of Sales, Wound Care ANZ | Molnlycke Health Care Pty Ltd |
Grace Woods | Strategic Partnership Manager | Edwards Lifesciences Pty Ltd |
Janie Fonua | Senior Quality Specialist | Arthrex Australia Pty Ltd |
Kylie Pearce | Corporate Account Manager | Olympus Australia Pty Ltd |
Elizabeth Pettit | Managing Director | Pettit Pharma & Device Search Pty Ltd |
Patrick Callanan | Business Unit Director, Interventional Cardiology and Structural Heart | Boston Scientific Pty Ltd |
Rebecca Meehan | Founder and Coach | MedTech Women's Coach |
Robyn Norton | Founding Director | The George Institute for Global Health |
Melina Georgousakis | Founding Director | Franklin Women |
Victoria Jones | Quality Manager | IDE Group |
Josh McLellan | Business Development Executive | Medtronic Australasia Pty Ltd |
Michelle Stewart | Director of Marketing & Digital | Device Technologies Australia Pty Ltd |
Naeema Mohamed | Director - Regulatory & Commercial Quality, ANZ | Smith & Nephew Pty Ltd |
Martie De Villiers | ANZ /NZ Biosimilars Pipeline Development and Brand Manager | Organon Pharma Pty Ltd |
Jane Walton | Renal Care Marketing Manager | Baxter Healthcare Pty Ltd |
Susan Tye | Managing Director | Heraeus Medical Australia |
Anna Mitchell | Institute Director ANZ | Zimmer Biomet Pty Ltd |